These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19730858)

  • 21. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
    Kawakami Y; Eliyahu S; Delgado CH; Robbins PF; Sakaguchi K; Appella E; Yannelli JR; Adema GJ; Miki T; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6458-62. PubMed ID: 8022805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens.
    Charpentier M; Croyal M; Carbonnelle D; Fortun A; Florenceau L; Rabu C; Krempf M; Labarrière N; Lang F
    Oncotarget; 2016 Sep; 7(37):59704-59713. PubMed ID: 27486971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes.
    Storkus WJ; Zeh HJ; Maeurer MJ; Salter RD; Lotze MT
    J Immunol; 1993 Oct; 151(7):3719-27. PubMed ID: 7690811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma.
    Rimoldi D; Rubio-Godoy V; Dutoit V; Lienard D; Salvi S; Guillaume P; Speiser D; Stockert E; Spagnoli G; Servis C; Cerottini JC; Lejeune F; Romero P; Valmori D
    J Immunol; 2000 Dec; 165(12):7253-61. PubMed ID: 11120859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.
    González FE; Ramírez M; Allerbring EB; Fasching N; Lundqvist A; Poschke I; Achour A; Salazar-Onfray F
    Immunobiology; 2014 Mar; 219(3):189-97. PubMed ID: 24192537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.
    Schneider J; Brichard V; Boon T; Meyer zum Büschenfelde KH; Wölfel T
    Int J Cancer; 1998 Jan; 75(3):451-8. PubMed ID: 9455808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intronic region of an incompletely spliced gp100 gene transcript encodes an epitope recognized by melanoma-reactive tumor-infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Fitzgerald EB; Kawakami Y; Rosenberg SA
    J Immunol; 1997 Jul; 159(1):303-8. PubMed ID: 9200467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L; Kawakami Y; Sakaguchi K; Southwood S; Sette A; Robbins PF; Marincola FM; Salgaller ML; Yannelli JR; Appella E
    J Immunol; 1995 Mar; 154(5):2257-65. PubMed ID: 7868898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression.
    Kawakami Y; Eliyahu S; Jennings C; Sakaguchi K; Kang X; Southwood S; Robbins PF; Sette A; Appella E; Rosenberg SA
    J Immunol; 1995 Apr; 154(8):3961-8. PubMed ID: 7706734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.
    Brichard V; Van Pel A; Wölfel T; Wölfel C; De Plaen E; Lethé B; Coulie P; Boon T
    J Exp Med; 1993 Aug; 178(2):489-95. PubMed ID: 8340755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.
    Kawakami Y; Eliyahu S; Delgado CH; Robbins PF; Rivoltini L; Topalian SL; Miki T; Rosenberg SA
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3515-9. PubMed ID: 8170938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene.
    Guilloux Y; Lucas S; Brichard VG; Van Pel A; Viret C; De Plaen E; Brasseur F; Lethé B; Jotereau F; Boon T
    J Exp Med; 1996 Mar; 183(3):1173-83. PubMed ID: 8642259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes.
    Seiter S; Monsurro V; Nielsen MB; Wang E; Provenzano M; Wunderlich JR; Rosenberg SA; Marincola FM
    J Immunother; 2002; 25(3):252-63. PubMed ID: 12000867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients.
    Valmori D; Liénard D; Waanders G; Rimoldi D; Cerottini JC; Romero P
    Cancer Res; 1997 Feb; 57(4):735-41. PubMed ID: 9044853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients.
    Benlalam H; Vignard V; Khammari A; Bonnin A; Godet Y; Pandolfino MC; Jotereau F; Dreno B; Labarrière N
    Cancer Immunol Immunother; 2007 Apr; 56(4):515-26. PubMed ID: 16874485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes.
    Robbins PF; El-Gamil M; Li YF; Kawakami Y; Loftus D; Appella E; Rosenberg SA
    J Exp Med; 1996 Mar; 183(3):1185-92. PubMed ID: 8642260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of shared MHC-restricted human melanoma antigens after vaccinia virus-mediated transduction of genes coding for HLA.
    O'Neil BH; Kawakami Y; Restifo NP; Bennink JR; Yewdell JW; Rosenberg SA
    J Immunol; 1993 Aug; 151(3):1410-8. PubMed ID: 8335937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ; Jacknin L; Robbins PF; Kawakami Y; el Gamil M; Rosenberg SA; Yannelli JR
    J Immunol; 1995 Jan; 154(2):762-71. PubMed ID: 7814882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanoma antigen recognition by tumour-infiltrating T lymphocytes (TIL): effect of differential expression of melan-A/MART-1.
    Ramirez-Montagut T; Andrews DM; Ihara A; Pervaiz S; Pandolfi F; Van Den Elsen PJ; Waitkus R; Boyle LA; Hishii M; Kurnick JT
    Clin Exp Immunol; 2000 Jan; 119(1):11-8. PubMed ID: 10606959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes.
    Bakker AB; Schreurs MW; de Boer AJ; Kawakami Y; Rosenberg SA; Adema GJ; Figdor CG
    J Exp Med; 1994 Mar; 179(3):1005-9. PubMed ID: 8113668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.